Results 131 to 140 of about 191,830 (167)
Pneumonia caused by co-infection with Mycobacterium tuberculosis and Pneumocystis jirovecii leading to acute respiratory distress syndrome in an HIV-negative immunocompromised patient: a case report and literature review. [PDF]
BMC Infect DisPan J, Kong H, Liang M, Fang X.
europepmc +1 more source
Infection-related and Hepatobiliary Death Outcome Reports Involving Avacopan in the Japanese Pharmacovigilance Database. [PDF]
In VivoIde N, Sako KI, Maeda T.
europepmc +1 more source
Blood mNGS: an effective non-invasive diagnostic tool for Pneumocystis jirovecii pneumonia. [PDF]
BMC MicrobiolChen Y +10 more
europepmc +1 more source
Pneumocystis jirovecii Pneumonia
Infectious Disease Clinics of North America, 2010 Pneumocystis jirovecii has gained attention during the last decade in the context of the AIDS epidemic and the increasing use of cytotoxic and immunosuppressive therapies. This article summarizes current knowledge on biology, pathophysiology, epidemiology, diagnosis, prevention, and treatment of pulmonary P jirovecii infection, with a particular focus ...
Catherinot, Emilie +5 more
openaire +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
New England Journal of Medicine, 2004
Abstract: Major controversies persist regarding the diagnosis and management of Pneumocystis pneumonia (PCP). Of considerable significance is the fact that much of the available evidence relates to human immunodeficiency virus (HIV)–infected subjects and may not be applicable to other immunocompromised groups.
Charles F, Thomas, Andrew H, Limper
+6 more sources
Abstract: Major controversies persist regarding the diagnosis and management of Pneumocystis pneumonia (PCP). Of considerable significance is the fact that much of the available evidence relates to human immunodeficiency virus (HIV)–infected subjects and may not be applicable to other immunocompromised groups.
Charles F, Thomas, Andrew H, Limper
+6 more sources
Pediatric Clinics of North America, 1958
Pneumocystis carinii pneumonia or interstitial plasma-cell pneumonia is a common infection in Europe, where it occurs endemically or in small institutional epidemics. It affects chiefly premature or otherwise debilitated infants with a peak incidence at the age from 6 weeks to 4 months, but the disease has also been encountered in three adults.1In this
R M, HOWARD, W H, SHELDON
openaire +4 more sources
Pneumocystis carinii pneumonia or interstitial plasma-cell pneumonia is a common infection in Europe, where it occurs endemically or in small institutional epidemics. It affects chiefly premature or otherwise debilitated infants with a peak incidence at the age from 6 weeks to 4 months, but the disease has also been encountered in three adults.1In this
R M, HOWARD, W H, SHELDON
openaire +4 more sources
Seminars in Respiratory and Critical Care Medicine, 2011
Pneumocystis (carinii) jiroveci pneumonia can occur in immunocompromised individuals, especially hematopoietic stem and solid organ transplant recipients and those receiving immunosuppressive agents, and is the most common opportunistic infection in persons with advanced human immunodeficiency virus (HIV) infection. The Pneumocystis genus was initially
Shelley A, Gilroy, Nicholas J, Bennett
openaire +3 more sources
Pneumocystis (carinii) jiroveci pneumonia can occur in immunocompromised individuals, especially hematopoietic stem and solid organ transplant recipients and those receiving immunosuppressive agents, and is the most common opportunistic infection in persons with advanced human immunodeficiency virus (HIV) infection. The Pneumocystis genus was initially
Shelley A, Gilroy, Nicholas J, Bennett
openaire +3 more sources